Rapid Micro Biosystems
Update in progressRPID (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Rapid Micro Biosystems is a life sciences technology company providing automated microbial contamination testing for pharma, biologics, medical devices, and personal care products. Its Growth Direct platform combines a handling system, proprietary consumables, LIMS integration software, and support to modernize MQC workflows for biologics, cell and gene therapies, vaccines, and sterile injectables. It also offers RMBNucleus Mold Alarm, Growth Direct LIMS, onsite training, and environmental, bioburden, and sterility testing. Based in Lexington, MA.
Company score
- Sentiment
- 0.45
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.06
- Governance
- 0.12
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.05
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.25
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!